Skip to content
cccskills
FreePublished on GitHub

es-check-one-year-hormone-therapy-surgery

Determines if a patient has completed ≥1 year of consistent and compliant hormone therapy for genital surgery approval. Triggers include patient requesting genital surgery and being on hormone therapy.

The English summary is being prepared. Showing the original description.

Run score Not tested

See how to install

Files included (1)

  • SKILL.md2.1 KB

SKILL.md (original)

Review the instructions the agent will receive before you install.

Check if ≥1 year compliant hormone therapy for surgery approval

STEP 1 — Gather Information

Collect hormone therapy start date, type, dosage, adherence pattern, assess for medical contraindications, and confirm patient’s desire to continue hormones and request for genital surgery.

STEP 2 — Rule In / Rule Out

Is hormone therapy desired and not medically contraindicated? If yes, proceed to Step 3; if no, surgery may be approved without the 1‑year requirement per guideline exception.

STEP 3 — Classify or Stratify

Has the patient completed ≥1 year of consistent and compliant hormone therapy? If yes, classify as eligible; if no, classify as not eligible.

STEP 4 — Decide

If eligible, approve genital gender‑affirming surgery; if not eligible, defer surgery until ≥1 year of therapy is achieved (unless hormone therapy is not desired or medically contraindicated, already addressed in Step 2).

Clinical Guardrails / Mimics / Pitfalls

Do not approve surgery based on patient request alone without verifying therapy duration and adherence; do not overlook intermittent use or non‑compliance; do not ignore medical contraindications that make hormone therapy unsafe; do not assume compliance without documentation; remember that the 1‑year rule is waived only when hormone therapy is not desired or medically contraindicated.

Concrete Clinical Example

A 26‑year‑on trans man requests metoidioplasty. He has been on testosterone 100 mg IM weekly for 10 months with good adherence, no contraindications, and desires hormones. Duration <1 year → defer surgery until 12‑month mark.

Source: Endocrine Society Clinical Practice Guideline, Endocrine Society, 2017, https://doi.org/10.1210/jc.2017-01658

TODO: consider adding scripts/calc.py for the es-check-one-year-hormone-therapy-surgery calculator

Reviews

No reviews yet. Tell others what you thought.

Comments

No login needed. Share how it worked for you, ask a question, or note where it did not run.

No comments yet. Be the first to write one.

Comments are published right away. Do not include personal information such as email addresses or phone numbers. Up to 2 URLs.

0 / 1,000 characters

This form is protected by reCAPTCHA, and the Google Privacy Policy and Terms of Service apply.

More skills from this repository

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

See all skills by dromlakhani

Report a problem with this skill